Cargando…
Neoadjuvant chemotherapy and radiotherapy followed by resection/ablation in stage IV rectal cancer patients with potentially resectable metastases
BACKGROUND: The optimal treatment of stage IV rectal cancer remains controversial. The purpose of this study was to assess the treatment outcomes and toxicity of neoadjuvant chemotherapy and radiotherapy followed by local treatment of all tumor sites and subsequent adjuvant chemotherapy in stage IV...
Autores principales: | Li, Rongzhen, Wang, Qiaoxuan, Zhang, Bin, Yuan, Yan, Xie, Weihao, Huang, Xiaoxue, Zhou, Chengjing, Zhang, Shu, Niu, Shaoqing, Chang, Hui, Chen, Dongni, Miao, Huikai, Zeng, Zhi Fan, Xiao, Weiwei, Gao, Yuanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672531/ https://www.ncbi.nlm.nih.gov/pubmed/34906114 http://dx.doi.org/10.1186/s12885-021-09089-5 |
Ejemplares similares
-
Colorectal cancer, radiotherapy and gut microbiota
por: Zhang, Shu, et al.
Publicado: (2019) -
Outcomes and toxicities of immune checkpoint inhibitors in colorectal cancer: a real‐world retrospective analysis
por: Zhou, Chengjing, et al.
Publicado: (2021) -
Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer
por: Chin, Re-I, et al.
Publicado: (2022) -
Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
por: Nichols, Romaine Charles, et al.
Publicado: (2019) -
Resection of colorectal liver metastases following neoadjuvant chemotherapy
por: Chiappa, A, et al.
Publicado: (2007)